Shannon L. Maude

机构：Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia University · ORCID：0000-0003-2210-8736

发表论文 279 篇 · 总被引 26441 次 · h-index 56

代表论文

• Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies (2025 · Nature Medicine · 被引 75)
• TET2 regulates early and late transitions in exhausted CD8 + T cell differentiation and limits CAR T cell function (2024 · Science Advances · 被引 30)
• Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies (2025 · Blood · 被引 23)
• CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy (2025 · Journal for ImmunoTherapy of Cancer · 被引 21)
• Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy (2024 · Blood Advances · 被引 7)
• Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers (2025 · Transplantation and Cellular Therapy · 被引 6)